Medicalization and Pharmaceuticalization

Medicalization is the sociological term for the process through which non-medical problems come to be defined and treated as medical problems, usually as illnesses or disorders. The concept was powerfully developed and popularized by Irving K. Zola in a celebrated 1972 article titled Medicine as an Institution of Social Control, which argued that medicine was steadily replacing religion and law as the dominant institution regulating deviance in modern societies. Where earlier eras treated drunkards as sinners and criminals, modern society increasingly treats them as patients suffering from alcohol use disorder. Where masturbation had once been a moral problem, obesity a matter of gluttony, and unruly children a problem of discipline, each was being translated into a diagnostic category with a medical treatment. Zola's essay opened a flood of empirical work mapping the expansion of medical jurisdiction.

Peter Conrad inherited and developed the concept most systematically. His co-authored Deviance and Medicalization: From Badness to Sickness (1980, with Joseph Schneider) traced how conditions including alcoholism, hyperactivity in children, homosexuality (until its removal from the DSM in 1973), and criminal violence had been variably medicalized and de-medicalized over the twentieth century. His later book The Medicalization of Society (2007) extended the analysis to a post-1980 landscape in which, he argued, the drivers of medicalization had shifted decisively. In the earlier era, doctors and moral entrepreneurs were the primary agents expanding medical jurisdiction. In the contemporary era, the drivers were increasingly the pharmaceutical industry, biotechnology firms, consumer demand, and managed care — a shift with profound implications for which conditions become medicalized, how, and for whose benefit.

Conrad distinguishes three analytic levels at which medicalization occurs. At the conceptual level, a problem is redefined in medical vocabulary (shyness becomes social anxiety disorder). At the institutional level, medical organizations claim jurisdiction (insurers cover the treatment, professional societies issue guidelines). At the interactional level, doctor-patient encounters treat the condition medically (the physician prescribes a drug). Full medicalization involves all three; partial medicalization is common. The concept is descriptive, not necessarily critical — some medicalization is welcome (effective treatment of previously moralized conditions like epilepsy) while other instances are contested (pathologizing ordinary sadness as depression requiring drugs).